NO165106C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aminoalkyl-beta-carbolinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aminoalkyl-beta-carbolinderivater.

Info

Publication number
NO165106C
NO165106C NO865180A NO865180A NO165106C NO 165106 C NO165106 C NO 165106C NO 865180 A NO865180 A NO 865180A NO 865180 A NO865180 A NO 865180A NO 165106 C NO165106 C NO 165106C
Authority
NO
Norway
Prior art keywords
lower alkyl
aminoalkyl
preparation
hydrogen
therapeutic active
Prior art date
Application number
NO865180A
Other languages
English (en)
Norwegian (no)
Other versions
NO865180L (no
NO165106B (no
NO865180D0 (no
Inventor
Helmut Biere
Andreas Huth
Dieter Rahtz
Ralph Schmiechen
Dieter Seidelmann
David Norman Stephens
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO865180D0 publication Critical patent/NO865180D0/no
Publication of NO865180L publication Critical patent/NO865180L/no
Publication of NO165106B publication Critical patent/NO165106B/no
Publication of NO165106C publication Critical patent/NO165106C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Braking Arrangements (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO865180A 1985-12-20 1986-12-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aminoalkyl-beta-carbolinderivater. NO165106C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853545776 DE3545776A1 (de) 1985-12-20 1985-12-20 5-aminoalkyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel

Publications (4)

Publication Number Publication Date
NO865180D0 NO865180D0 (no) 1986-12-19
NO865180L NO865180L (no) 1987-06-22
NO165106B NO165106B (no) 1990-09-17
NO165106C true NO165106C (no) 1990-12-27

Family

ID=6289387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865180A NO165106C (no) 1985-12-20 1986-12-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aminoalkyl-beta-carbolinderivater.

Country Status (17)

Country Link
US (2) US4731365A (fi)
EP (1) EP0232675B1 (fi)
JP (1) JPH0780878B2 (fi)
AT (1) ATE58536T1 (fi)
AU (1) AU597923B2 (fi)
CA (1) CA1277319C (fi)
DD (1) DD252829A5 (fi)
DE (2) DE3545776A1 (fi)
DK (1) DK165878C (fi)
ES (1) ES2031457T3 (fi)
FI (1) FI82245C (fi)
GR (1) GR3001468T3 (fi)
HU (1) HU195656B (fi)
IE (1) IE59757B1 (fi)
IL (1) IL81003A (fi)
NO (1) NO165106C (fi)
PT (1) PT83975B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609699A1 (de) * 1986-03-20 1987-09-24 Schering Ag 5- oder 6-substituierte-(beta)-carbolin-3-carbonsaeureester
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
DE4212529A1 (de) * 1992-04-10 1993-10-14 Schering Ag Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten
DE4330175A1 (de) * 1993-08-31 1995-03-02 Schering Ag Alkoxy-substituierte beta-Carboline
EP4144707A1 (de) 2021-09-07 2023-03-08 Biolac GmbH & Co. KG Mischung zur herstellung eines formkörpers mit verbessertem bindemittel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3322895A1 (de) * 1983-06-23 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ss-carboline, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel (s)
DE3322894A1 (de) * 1983-06-23 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue (beta)-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel (h)
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DK240084D0 (da) * 1984-05-15 1984-05-15 Ferrosan As New beta-carboline-3-oxadiazolyl derivatives
DE3504045A1 (de) * 1985-02-04 1986-08-07 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von ss-carbolinen durch dehydrierung

Also Published As

Publication number Publication date
AU6679786A (en) 1987-06-25
FI82245B (fi) 1990-10-31
US4757070A (en) 1988-07-12
NO865180L (no) 1987-06-22
NO165106B (no) 1990-09-17
FI865234A0 (fi) 1986-12-19
IL81003A (en) 1990-04-29
DE3675758D1 (de) 1991-01-03
ATE58536T1 (de) 1990-12-15
JPH0780878B2 (ja) 1995-08-30
IE59757B1 (en) 1994-03-23
DK165878C (da) 1993-06-21
AU597923B2 (en) 1990-06-14
GR3001468T3 (en) 1992-10-08
JPS62195378A (ja) 1987-08-28
DE3545776A1 (de) 1987-06-25
FI865234A (fi) 1987-06-21
DK610586D0 (da) 1986-12-17
DK610586A (da) 1987-06-21
EP0232675B1 (de) 1990-11-22
DK165878B (da) 1993-02-01
DD252829A5 (de) 1987-12-30
ES2031457T3 (es) 1992-12-16
EP0232675A1 (de) 1987-08-19
US4731365A (en) 1988-03-15
NO865180D0 (no) 1986-12-19
CA1277319C (en) 1990-12-04
PT83975B (pt) 1989-05-12
IE863329L (en) 1987-06-20
IL81003A0 (en) 1987-03-31
HUT43068A (en) 1987-09-28
HU195656B (en) 1988-06-28
PT83975A (en) 1987-01-01
FI82245C (fi) 1991-02-11

Similar Documents

Publication Publication Date Title
DK586588A (da) Terapeutiske heterocycliske forbindelser
IE830897L (en) Dihydropyridine derivatives.
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
NO892058L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzamider.
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO163735C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkyl-beta-carboliner.
NO168890C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive acylcephalosporinderivater
NO164978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaryloxy-beta-carbolinderivater.
NO168418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
NO160783C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte beta-karbolinderivater.
NO165106C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aminoalkyl-beta-carbolinderivater.
NO164354C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,8-tetrahydro-beta-carbolinderivater.
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
DK614989D0 (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
HU913293D0 (en) Process for the production of pierazine derivatives and medical preparations containing them